These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24029362)

  • 1. Re: Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer.
    Atala A
    J Urol; 2013 Oct; 190(4):1437. PubMed ID: 24029362
    [No Abstract]   [Full Text] [Related]  

  • 2. Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer.
    Saito R; Shirakawa R; Nishiyama H; Kobayashi T; Kawato M; Kanno T; Nishizawa K; Matsui Y; Ohbayashi T; Horiguchi M; Nakamura T; Ikeda T; Yamane K; Nakayama E; Nakamura E; Toda Y; Kimura T; Kita T; Ogawa O; Horiuchi H
    Oncogene; 2013 Feb; 32(7):894-902. PubMed ID: 22450745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro conversion of carcinoma cells into fibroblastic cells. Induction, mechanism of action and importance in invasion and metastasis].
    Boyer B; Valles AM; Jouanneau J; Tucker G; Delouvée A; Moens G; Thiery JP
    Pathol Biol (Paris); 1992 Nov; 39(9):862-3. PubMed ID: 1371605
    [No Abstract]   [Full Text] [Related]  

  • 4. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.
    Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY
    Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.
    Miyake M; Fujimoto K; Anai S; Ohnishi S; Kuwada M; Nakai Y; Inoue T; Matsumura Y; Tomioka A; Ikeda T; Tanaka N; Hirao Y
    Oncol Rep; 2011 Mar; 25(3):653-60. PubMed ID: 21206978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor gene alterations in bladder carcinoma. Translational correlates to clinical practice.
    Dalbagni G; Cordon-Cardo C; Reuter V; Fair WR
    Surg Oncol Clin N Am; 1995 Apr; 4(2):231-40. PubMed ID: 7796283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rb deficiency accelerates progression of carcinoma of the urinary bladder in vivo and in vitro through inhibiting autophagy and apoptosis.
    Wang CY; Xu ZB; Wang JP; Jiao Y; Zhang B
    Int J Oncol; 2017 Apr; 50(4):1221-1232. PubMed ID: 28259945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of a new cell line (YTS-1) derived from a human urinary bladder carcinoma and its characteristics].
    Kakizaki H; Numasawa K; Suzuki K
    Nihon Hinyokika Gakkai Zasshi; 1986 Nov; 77(11):1790-5. PubMed ID: 3573461
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
    Du P; Wang S; Tang X; An C; Yang Y; Jiang WG
    Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial comment from Dr Borkowska to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading.
    Borkowska EM
    Int J Urol; 2014 Oct; 21(10):974-5. PubMed ID: 24976179
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading.
    Todenhöfer T; Schwentner C
    Int J Urol; 2014 Oct; 21(10):973. PubMed ID: 24947315
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading.
    Lodde M; Mian C; Mayr R; Comploj E; Trenti E; Melotti R; Campodonico F; Maffezzini M; Fritsche HM; Pycha A
    Int J Urol; 2014 Oct; 21(10):974. PubMed ID: 24947451
    [No Abstract]   [Full Text] [Related]  

  • 13. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis.
    Kanehira M; Harada Y; Takata R; Shuin T; Miki T; Fujioka T; Nakamura Y; Katagiri T
    Oncogene; 2007 Sep; 26(44):6448-55. PubMed ID: 17452976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
    Xu ST; Ding X; Ni QF; Jin SJ
    Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β1 promotes the migration and invasion of bladder carcinoma cells by increasing fascin1 expression.
    Zhang N; Bi X; Zeng Y; Zhu Y; Zhang Z; Liu Y; Wang J; Li X; Bi J; Kong C
    Oncol Rep; 2016 Aug; 36(2):977-83. PubMed ID: 27350089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells.
    Harada Y; Kanehira M; Fujisawa Y; Takata R; Shuin T; Miki T; Fujioka T; Nakamura Y; Katagiri T
    Cancer Res; 2010 Jul; 70(14):5829-39. PubMed ID: 20587513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Classification and natural history of bladder tumors].
    Allory Y
    Rev Prat; 2014 Dec; 64(10):1365-6, 1368-71. PubMed ID: 25668829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder cancer subtypes defined by genomic alterations.
    Knowles MA
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):116-30. PubMed ID: 18815926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.